← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2011Last known activity
Feb 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 7 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT06710184CollaboratorPhase 4Feb 1, 2025
- NCT05662527CollaboratorPhase 2Jan 31, 2023
- NCT05636501CollaboratorN/ADec 31, 2022
- NCT05440240Study directorPhase 4Sep 30, 2022
- NCT05447533CollaboratorN/ASep 1, 2022
- NCT01414569CollaboratorPhase 4Nov 1, 2011
- NCT01357044Lead sponsorN/AMay 1, 2011
- NCT01357044Reponsible party - principal investigatorN/AMay 1, 2011
Details
- Last known activity
- Feb 1, 2025